Eli Lilly & Co. shares surged 10% after the pharmaceutical giant posted Q4 2025 results that smashed analyst forecasts and issued a robust 2026 outlook, powered by unprecedented demand for its GLP-1 drugs Mounjaro and Zepbound.
Novo Nordisk announced Wednesday the upcoming U.S. launch of its oral semaglutide tablets under the Ozempic brand, with FDA approval secured for multiple doses. The move marks a significant shift for the popular diabetes treatment from injection to pill form.
Dollar General has agreed to an $8.5 million class action settlement to resolve allegations of overcharging customers at checkout. Eligible shoppers who made purchases between 2016 and 2025 may file claims for compensation and in-store benefits.
Alex Saab, a close ally of President Nicolás Maduro and former Venezuelan minister, has been arrested in Caracas according to Colombian media reports, just months after his high-profile release from U.S. custody in a prisoner exchange deal.
USA Rare Earth lands a pivotal role in America's critical minerals strategy, securing a potential $1.6 billion federal package and new private investment to build a domestic supply chain from mine to magnet.
ADP reported strong quarterly earnings and raised its full-year guidance, while unveiling new AI-powered 'Assist' agents designed to automate HR and payroll tasks. The move highlights the company's strategy to monetize its vast employment dataset, even as investors question its growth trajectory and the costs of AI integration.
Axsome Therapeutics' preliminary 2025 results reveal blockbuster-level sales for its depression drug Auvelity, while investor focus intensifies on its potential FDA label expansion for Alzheimer's disease agitation—a move that could redefine the company's valuation and pipeline prospects.
The United States and Mexico have launched a two-month initiative to align their trade policies on critical minerals, a move seen as bolstering North American supply chain resilience against global disruptions. The plan includes exploring binding price mechanisms and could signal a broader strategy to reduce dependency on dominant processors like China.
As a top GOP donor issues a rare public rebuke of Trump's Fed attacks, investors are looking to time-tested assets to shield their wealth from inflation's relentless erosion.
Precious metals claw back gains for a second consecutive session, with analysts debating the sustainability of the recovery amid ongoing market volatility and central bank demand forecasts.
A coalition of 43 state attorneys general has filed a sweeping lawsuit accusing pharmaceutical giant Novartis and its former subsidiary Sandoz of orchestrating a massive bid-rigging scheme for 31 generic drugs, calling it one of the most brazen conspiracies ever uncovered in the industry.
Contrary to widespread economic predictions, aggressive U.S. tariff policies have not stalled growth, forcing a reassessment of trade shock models and policy impacts.
PepsiCo shares have surged over 16% in the past year, outpacing major indices. Following strong Q4 earnings and strategic price reductions on key snack brands, Wall Street maintains a cautiously optimistic 'Moderate Buy' stance, though targets suggest modest upside.
In a major settlement with the Federal Trade Commission, Cigna's pharmacy benefit manager, Express Scripts, has agreed to overhaul its drug pricing practices, particularly for insulin, a move regulators estimate could save patients billions over the next decade.
As Qualcomm prepares to report Q1 FY2026 earnings, the chipmaker faces a pivotal moment. Mounting competition from Apple's in-house modems, a slowing handset market, and regulatory pressures in China have investors on edge, setting the stage for a report that could redefine the stock's trajectory.
The latest American Customer Satisfaction Index report for 2026 crowns Trader Joe's as the nation's highest-rated grocer, ending a tie with Publix. The win highlights shifting consumer preferences and regional divides in the competitive supermarket landscape.
A sharp reversal in institutional ETF flows, weakening U.S. demand, and tightening market liquidity are signaling a potential regime shift for Bitcoin, with analysts warning of further downside risk.
Silicon Motion Technology (SIMO) reported robust Q4 2025 results, surpassing revenue and margin targets, as executives outlined a bullish outlook fueled by AI infrastructure needs, PCIe Gen5 adoption, and strategic market share gains. The company forecasts continued sequential growth through 2026, targeting record annual revenue despite industry-wide memory supply constraints.
ATI's shares have more than doubled over the past 12 months, fueled by its strategic position in capital goods and aerospace. As the stock trades near $128, analysts are divided on whether the current valuation still offers room for growth or signals a pause.
Shares of Simply Good Foods (SMPL) have tumbled over 50% in the past year, starkly contrasting with its steady profitability. With a fair value estimate pointing to significant upside, investors are debating whether this is a rare buying opportunity or a sign of deeper challenges in the health snack sector.
